BC

Byrareddy Cheemalagutta Manjunath

Active Director Director DIN 10914196
DIN 10914196 First appointment Jan 2025 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Byrareddy Cheemalagutta Manjunath

Data last updated:

Byrareddy Cheemalagutta Manjunath is a Director at Medidrogue Pharmaceuticals Private Limited (since 2025). The company operates in Paper.

DIN 10914196
Primary Designation Director
Industry Paper
First Appointment 21 Jan 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Jan 20252025Active

Board colleagues of Byrareddy Cheemalagutta Manjunath

Directorship timeline

Open interactive timeline →
Medidrogue Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Byrareddy Cheemalagutta Manjunath

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Byrareddy Cheemalagutta Manjunath

Byrareddy Cheemalagutta Manjunath currently holds 1 directorship: Medidrogue Pharmaceuticals Private Limited (Director, since 21 Jan 2025).

Byrareddy Cheemalagutta Manjunath was first appointed on 21 Jan 2025 as Director at Medidrogue Pharmaceuticals Private Limited.

The current boards of Byrareddy Cheemalagutta Manjunath's companies include Murali Gurappa Ramachandrappa (Medidrogue Pharmaceuticals Private Limited), Narayana Swamy Chowda Reddy (Medidrogue Pharmaceuticals Private Limited), Narayana Swamy Jagadeesh (Medidrogue Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available